D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CSTL holding history
Castle Biosciences Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CSTL overviewAll 13F holders of CSTLFull Q2 2026 holdings
- Shares (Q2 2026)
- 112,789
- Value
- $2.69M
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 112,789 | $2.69M | <0.1% | −99,177−46.8% | Reduced | Holders |
| Q1 2026 | 211,966 | $5.20M | <0.1% | +52,257+32.7% | Added | Holders |
| Q4 2025 | 159,709 | $6.21M | <0.1% | +67,095+72.4% | Added | Holders |
| Q3 2025 | 92,614 | $2.11M | <0.1% | −55,576−37.5% | Reduced | Holders |
| Q2 2025 | 148,190 | $3.03M | <0.1% | −40,987−21.7% | Reduced | Holders |
| Q1 2025 | 189,177 | $3.79M | <0.1% | +98,614+108.9% | Added | Holders |
| Q4 2024 | 90,563 | $2.41M | <0.1% | +90,563 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −13,382−100.0% | Sold out | Holders |
| Q1 2024 | 13,382 | $296.4K | <0.1% | −38,982−74.4% | Reduced | Holders |
| Q4 2023 | 52,364 | $1.13M | <0.1% | +52,364 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −28,937−100.0% | Sold out | Holders |
| Q4 2022 | 28,937 | $681.2K | <0.1% | +1,405+5.1% | Added | Holders |
| Q3 2022 | 27,532 | $718.0K | <0.1% | +27,532 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −7,104−100.0% | Sold out | Holders |
| Q3 2021 | 7,104 | $472.0K | <0.1% | +7,104 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −19,153−100.0% | Sold out | Holders |
| Q1 2021 | 19,153 | $1.31M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.